Bone Hormone May Stop Chronic Back Pain at the Source

Chronic back pain affects millions worldwide, disrupting work, sleep, and daily life with no clear cure in sight. Now researchers at Johns Hopkins University have discovered that a hormone already used to treat bone loss might stop back pain where it starts.

The study, published in Bone Research, found that parathyroid hormone (PTH) doesn't just mask pain symptoms. It actually prevents pain-sensing nerves from growing into damaged areas of the spine.

Dr. Janet Crane led the research team using three different mouse models that mimic human spinal degeneration from aging, injury, and genetic factors. After one to two months of daily PTH injections, treated mice showed denser, stronger vertebrae and significantly reduced pain sensitivity.

But the real breakthrough came when researchers discovered how PTH works. The hormone activates bone-building cells called osteoblasts, which then produce a protein named Slit3. This protein acts like a biological stop sign, pushing pain nerves away from areas where they don't belong.

In damaged spines, pain nerves often invade regions they normally avoid, creating chronic discomfort. PTH treatment dramatically reduced these abnormal nerve fibers in the study. When scientists removed Slit3 from the mice, PTH lost its pain-relieving power entirely, confirming the protein's crucial role.

The findings may explain why some osteoporosis patients taking PTH-based medications report unexpected back pain relief. Since synthetic PTH is already approved for treating bone loss, the pathway to human trials could move faster than typical drug development.

Why This Inspires

For the estimated 80% of adults who will experience back pain at some point, this research offers something rare: hope for treating the cause, not just managing symptoms. Most current treatments focus on pain relief through medications, physical therapy, or surgery, but none address why the pain starts in the first place.

This discovery shows how understanding the biology of pain could lead to smarter treatments. Instead of blocking pain signals after they start, PTH might prevent them from forming at all by creating a protective barrier in damaged tissue.

Dr. Crane notes that human clinical trials are the essential next step before this approach can help patients. But the research lays a solid foundation, especially since PTH treatments are already well-studied and FDA-approved for other uses.

For people whose lives have been limited by constant back pain, unable to work full days or play with their children, the possibility of a treatment that repairs rather than just relieves offers genuine hope for reclaiming normal life.